Mark S. Shearman, EVP, CHIEF SCIENTIFIC OFFICER at Editas Medicine, Inc. (EDIT), sold 2,790 shares at $9.67 ($27K) on 2023-02-13, disclosed to the SEC on 2023-02-15.
Open-market sale of $27k EDIT by EVP, CHIEF SCIENTIFIC OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| AGTC | BUY | 2016-09-26 | $27K | — | Filing → |